Organization issues new guideline for treatment of early Parkinson’s disease

Study unravels mysteries of the aging Down syndrome brain
15 November 2021
Trial stopped early: Giving immunotherapy before targeted therapy improves survival in advanced melanoma
15 November 2021

Organization issues new guideline for treatment of early Parkinson’s disease

The American Academy of Neurology (AAN) has issued a guideline providing recommendations for treating movement symptoms, called motor symptoms, in people with early Parkinson’s disease. The guideline is published in the November 15, 2021, online issue of Neurology, the medical journal of the AAN, and is endorsed by the Parkinson’s Foundation. This guideline updates recommendations on dopaminergic medications that were published in the 2002 AAN guideline on the initiation of treatment for Parkinson’s disease.

Comments are closed.